Correlation Between Erasca and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both Erasca and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Werewolf Therapeutics, you can compare the effects of market volatilities on Erasca and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Werewolf Therapeutics.
Diversification Opportunities for Erasca and Werewolf Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Erasca and Werewolf is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Erasca i.e., Erasca and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between Erasca and Werewolf Therapeutics
Given the investment horizon of 90 days Erasca Inc is expected to under-perform the Werewolf Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Erasca Inc is 1.21 times less risky than Werewolf Therapeutics. The stock trades about -0.38 of its potential returns per unit of risk. The Werewolf Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 135.00 in Werewolf Therapeutics on December 1, 2024 and sell it today you would lose (11.00) from holding Werewolf Therapeutics or give up 8.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Erasca Inc vs. Werewolf Therapeutics
Performance |
Timeline |
Erasca Inc |
Werewolf Therapeutics |
Erasca and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Erasca and Werewolf Therapeutics
The main advantage of trading using opposite Erasca and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |